Postpartum Depression Drug Market to USD 25.05 Billion by 2030 at 26.65% CAGR

The 𝐏𝐨𝐬𝐭𝐩𝐚𝐫𝐭𝐮𝐦 𝐃𝐞𝐩𝐫𝐞𝐬𝐬𝐢𝐨𝐧 𝐝𝐫𝐮𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 was valued at USD 7.43 billion in 2023 and is projected to grow at a CAGR of 26.65% during the forecast period from 2024 to 2030, reaching nearly USD 25.05 billion by 2030. This rapid growth is driven by advancements in drug development and increasing awareness of postpartum mental health.

𝐏𝐨𝐬𝐭𝐩𝐚𝐫𝐭𝐮𝐦 𝐃𝐞𝐩𝐫𝐞𝐬𝐬𝐢𝐨𝐧 𝐝𝐫𝐮𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:

Postpartum depression (PPD) is a medical condition characterized by intense feelings of sadness, anxiety, and fatigue following childbirth. It is a subset of perinatal depression occurring during pregnancy or within the first year postpartum. The market is expanding with the introduction of innovative therapies like Brexanolone and Zuranolone, the first FDA-approved medications specifically for PPD. These drugs offer rapid and effective relief, marking a significant shift in treatment approaches. The market growth is also supported by increasing awareness campaigns, improved diagnostic practices, and a growing focus on maternal mental health across healthcare systems worldwide.

𝐖𝐚𝐧𝐭 𝐭𝐨 𝐒𝐞𝐞 𝐭𝐡𝐞 𝐓𝐫𝐞𝐧𝐝𝐬? 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐚 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐓𝐨𝐝𝐚𝐲:https://www.stellarmr.com/report/req_sample/postpartum-depression-drug-market/2462

𝐃𝐫𝐢𝐯𝐞𝐫𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐏𝐨𝐬𝐭𝐩𝐚𝐫𝐭𝐮𝐦 𝐃𝐞𝐩𝐫𝐞𝐬𝐬𝐢𝐨𝐧 𝐝𝐫𝐮𝐠 𝐌𝐚𝐫𝐤𝐞𝐭:

The rising prevalence of postpartum depression and enhanced diagnostic capabilities are key drivers of the market. Improved awareness, coupled with decreasing stigma surrounding mental health, has led to more women seeking diagnosis and treatment. The development of advanced drugs like Brexanolone, which provides rapid symptom relief, and the convenient oral therapy Zuranolone, is transforming the treatment landscape. Additionally, healthcare initiatives focusing on maternal mental health and public education campaigns are encouraging more women to access effective therapeutic options, driving demand for PPD drugs.

𝐏𝐨𝐬𝐭𝐩𝐚𝐫𝐭𝐮𝐦 𝐃𝐞𝐩𝐫𝐞𝐬𝐬𝐢𝐨𝐧 𝐝𝐫𝐮𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬:

The expansion of personalized and combination therapies is a notable trend in the postpartum depression drug market. Tailored treatments, which combine antidepressants with psychotherapy or adjunctive options like hormonal therapies, address diverse patient needs and enhance efficacy. The growing adoption of innovative drug delivery methods, such as oral neuroactive steroids, is improving patient convenience and compliance. Regionally, North America leads the market due to advanced healthcare infrastructure and early adoption of novel therapies, while the Asia-Pacific region shows significant growth potential driven by rising awareness and improving healthcare access in countries like India, China, and Japan.

𝐓𝐡𝐞 𝐈𝐧𝐭𝐞𝐫𝐞𝐬𝐭𝐞𝐝 𝐒𝐭𝐚𝐤𝐞𝐡𝐨𝐥𝐝𝐞𝐫𝐬 𝐜𝐚𝐧 𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:https://www.stellarmr.com/report/enquire_now/postpartum-depression-drug-market/2462

𝐌𝐞𝐫𝐠𝐞𝐫𝐬 𝐚𝐧𝐝 𝐀𝐜𝐪𝐮𝐢𝐬𝐢𝐭𝐢𝐨𝐧𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐏𝐨𝐬𝐭𝐩𝐚𝐫𝐭𝐮𝐦 𝐃𝐞𝐩𝐫𝐞𝐬𝐬𝐢𝐨𝐧 𝐝𝐫𝐮𝐠 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐆𝐥𝐨𝐛𝐚𝐥 𝐔𝐩𝐝𝐚𝐭𝐞𝐬

𝐆𝐫𝐨𝐰𝐭𝐡 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬 𝐢𝐧 𝐕𝐢𝐞𝐭𝐧𝐚𝐦

Vietnam is seeing a rise in the diagnosis and treatment of postpartum depression, largely due to increased public health initiatives. The market grew by 7.5% in 2023, driven by urbanization and the growing availability of specialized mental health services. Companies like Sage Therapeutics and Pfizer are expanding their presence in Vietnam through collaborations with local healthcare providers and government programs aimed at mental health awareness.

𝐏𝐨𝐬𝐭𝐩𝐚𝐫𝐭𝐮𝐦 𝐃𝐞𝐩𝐫𝐞𝐬𝐬𝐢𝐨𝐧 𝐃𝐫𝐮𝐠 𝐓𝐫𝐞𝐧𝐝𝐬 𝐢𝐧 𝐓𝐡𝐚𝐢𝐥𝐚𝐧𝐝

Thailand's postpartum depression drug market is on the rise, bolstered by the government's focus on maternal healthcare. In 2023, the market witnessed an 8% year-on-year growth, with an increase in the prescription of selective serotonin reuptake inhibitors (SSRIs). Key players such as GlaxoSmithKline (GSK) and Eli Lilly are partnering with Thai hospitals to provide affordable and effective treatment options.

𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬 𝐢𝐧 𝐉𝐚𝐩𝐚𝐧'𝐬 𝐏𝐨𝐬𝐭𝐩𝐚𝐫𝐭𝐮𝐦 𝐃𝐞𝐩𝐫𝐞𝐬𝐬𝐢𝐨𝐧 𝐃𝐫𝐮𝐠 𝐌𝐚𝐫𝐤𝐞𝐭

Japan's aging population and highly advanced healthcare infrastructure are creating opportunities for the postpartum depression drug market. The market grew by 9.2% in 2023, driven by government support for mental health programs and the introduction of innovative therapies. Companies like Shionogi & Co. and Takeda Pharmaceuticals are leading the market with groundbreaking drug developments tailored to postpartum depression.

𝐒𝐨𝐮𝐭𝐡 𝐊𝐨𝐫𝐞𝐚'𝐬 𝐏𝐨𝐬𝐭𝐩𝐚𝐫𝐭𝐮𝐦 𝐃𝐞𝐩𝐫𝐞𝐬𝐬𝐢𝐨𝐧 𝐃𝐫𝐮𝐠 𝐆𝐫𝐨𝐰𝐭𝐡

South Korea's postpartum depression drug market is experiencing robust growth due to the country's emphasis on mental health and wellness. The government allocated USD 50 million in 2023 to improve maternal mental health services. Leading pharmaceutical companies such as Hanmi Pharmaceutical and Sage Therapeutics are actively collaborating to develop localized solutions that cater to the unique needs of South Korean mothers.

𝐓𝐫𝐞𝐧𝐝𝐬 𝐢𝐧 𝐒𝐢𝐧𝐠𝐚𝐩𝐨𝐫𝐞'𝐬 𝐏𝐨𝐬𝐭𝐩𝐚𝐫𝐭𝐮𝐦 𝐃𝐞𝐩𝐫𝐞𝐬𝐬𝐢𝐨𝐧 𝐃𝐫𝐮𝐠 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲

Singapore's focus on mental health has significantly boosted the demand for postpartum depression drugs. Imports of advanced therapeutic solutions increased by 12% in 2023, with companies like Novartis and Pfizer strengthening their foothold in the market. Collaborative efforts between government health agencies and global pharmaceutical firms are driving innovation in treatment options.

𝐆𝐫𝐨𝐰𝐭𝐡 𝐢𝐧 𝐭𝐡𝐞 𝐔𝐒 𝐏𝐨𝐬𝐭𝐩𝐚𝐫𝐭𝐮𝐦 𝐃𝐞𝐩𝐫𝐞𝐬𝐬𝐢𝐨𝐧 𝐃𝐫𝐮𝐠 𝐌𝐚𝐫𝐤𝐞𝐭

The United States remains the largest market for postpartum depression drugs, accounting for over 40% of global revenue in 2023. Increased awareness and the introduction of new therapies, such as Zuranolone by Sage Therapeutics, have been key drivers. Major companies, including Eli Lilly, are expanding their research efforts to develop faster-acting and longer-lasting treatments.

𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬 𝐢𝐧 𝐄𝐮𝐫𝐨𝐩𝐞'𝐬 𝐏𝐨𝐬𝐭𝐩𝐚𝐫𝐭𝐮𝐦 𝐃𝐞𝐩𝐫𝐞𝐬𝐬𝐢𝐨𝐧 𝐃𝐫𝐮𝐠 𝐌𝐚𝐫𝐤𝐞𝐭

Europe's postpartum depression drug market is growing steadily, driven by government initiatives and public awareness campaigns. Countries such as Germany, France, and the UK are leading the adoption of new therapies. Companies like GlaxoSmithKline (GSK) and H. Lundbeck A/S are investing in innovative drug solutions to meet the region's demand for effective postpartum depression treatments.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐮𝐥𝐥 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 @https://www.stellarmr.com/report/req_sample/postpartum-depression-drug-market/2462

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐏𝐨𝐬𝐭𝐩𝐚𝐫𝐭𝐮𝐦 𝐃𝐞𝐩𝐫𝐞𝐬𝐬𝐢𝐨𝐧 𝐝𝐫𝐮𝐠 𝐌𝐚𝐫𝐤𝐞𝐭:

By Drug Type

Zuranolone
Brexanolone
Others

By Treatment

Medication
Pharmacotherapy
Hormonal Therapy
Supplements
Electroconvulsive Therapy (ECT)
Others

By Route Administration

Oral
Parenteral
Others

By Distribution Channel

Hospital Pharmacies
Retail Pharmacy
Others (online pharmacy)

𝐅𝐨𝐫 𝐦𝐨𝐫𝐞 𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐯𝐢𝐬𝐢𝐭:https://www.stellarmr.com/report/postpartum-depression-drug-market/2462

𝐖𝐡𝐨 𝐢𝐬 𝐭𝐡𝐞 𝐥𝐚𝐫𝐠𝐞𝐬𝐭 𝐦𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐞𝐫𝐬 𝐨𝐟 𝐏𝐨𝐬𝐭𝐩𝐚𝐫𝐭𝐮𝐦 𝐃𝐞𝐩𝐫𝐞𝐬𝐬𝐢𝐨𝐧 𝐝𝐫𝐮𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐰𝐨𝐫𝐥𝐝𝐰𝐢𝐝𝐞?

Sun Pharmaceutical Industries Ltd
GH Research Ireland Limited (Ireland)
Cipla Inc.
Sage Therapeutics, Inc. (U.S.)
Biogen Inc. (U.S.)
Brii Biosciences Limited (China)
Pfizer Inc.
Bausch Health Companies Inc.
Eli Lilly and Company
GSK plc.
Merck & Co., Inc.
Biogen Inc.
Novartis AG
Teva Pharmaceutical Industries Ltd.
Lupin
SHIONOGI & Co., Ltd.
Aurobindo Pharma
Allergan, Inc
Mylan N. V
Johnson & Johnson Private Limited
Sanofi S. A

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐒𝐭𝐞𝐥𝐥𝐚𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

♦Machine Tools Market https://www.stellarmr.com/report/Machine-Tools-Market/204

♦Vibrating Screen Market https://www.stellarmr.com/report/Vibrating-Screen-Market/214

♦Industrial Automation Services Market https://www.stellarmr.com/report/Industrial-Automation-Services-Market/217

♦United Kingdom (UK) Carbon Neutral Market https://www.stellarmr.com/report/United-Kingdom-UK-Carbon-Neutral-Market/230

♦Nuclear Medicine Market https://www.stellarmr.com/report/nuclear-medicine-market/2443

♦Ambient Food Packaging Market https://www.stellarmr.com/report/Ambient-Food-Packaging-Market/244

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐒𝐭𝐞𝐥𝐥𝐚𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:
S.no.8, h.no. 4-8 Pl.7/4, Kothrud,
Pinnac Memories Fl. No. 3, Kothrud, Pune,
Pune, Maharashtra, 411029
sales@stellarmr.com

𝐀𝐛𝐨𝐮𝐭 𝐒𝐭𝐞𝐥𝐥𝐚𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

Stellar Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include science and engineering, electronic components, industrial equipment, technology, and communication, cars, and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

This release was published on openPR.